Acquired resistance to combination treatment through loss of synergy with MEK and PI3K inhibitors in colorectal cancer

Historically, understanding of acquired resistance (AQR) to combination treatment has been based on knowledge of resistance to its component agents. To test whether an altered drug interaction could be an additional factor in AQR to combination treatment, models of AQR to combination and single agen...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhattacharya, Bhaskar, Low, Sarah Hong Hui, Chong, Mei Ling, Chia, Dilys, Koh, King Xin, Sapari, Nur Sabrina, Kaye, Stanley, Hung, Huynh, Benoukraf, Touati, Soong, Richie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045388/
https://www.ncbi.nlm.nih.gov/pubmed/27081080
http://dx.doi.org/10.18632/oncotarget.8692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045388/
https://www.ncbi.nlm.nih.gov/pubmed/27081080
http://dx.doi.org/10.18632/oncotarget.8692

Ejemplares similares